Sandoz has extended until 31 January 2025 its existing master services agreement with Ares Genetics “to drive cutting-edge digital solutions in the global fight against antimicrobial resistance,” ahead of the next phase of the collaboration.
Sandoz And Ares Extend AMR Collaboration Ahead Of Next Phase
Initial December 2018 Agreement Extended Until January 2025
With plans to enable genomic surveillance for antimicrobial resistant pathogens using Ares’ next-generation sequencing and bioinformatics technologies, the OpGen subsidiary and Sandoz have shaken hands on an extension to their initial master services agreement.
